APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 53 filers reported holding APTOSE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -71.3% | 57,166 | -74.4% | 0.00% | – |
| Q4 2022 | $129 | -99.8% | 222,930 | +75.4% | 0.00% | – |
| Q3 2022 | $76,000 | -29.6% | 127,134 | -12.7% | 0.00% | – |
| Q2 2022 | $108,000 | -89.8% | 145,627 | -81.2% | 0.00% | -100.0% |
| Q1 2022 | $1,054,000 | -28.5% | 775,214 | -29.0% | 0.00% | 0.0% |
| Q4 2021 | $1,474,000 | -2.4% | 1,091,222 | +57.6% | 0.00% | 0.0% |
| Q3 2021 | $1,510,000 | +44.2% | 692,531 | +119.6% | 0.00% | 0.0% |
| Q2 2021 | $1,047,000 | -52.0% | 315,293 | -13.7% | 0.00% | -50.0% |
| Q1 2021 | $2,183,000 | +150.6% | 365,431 | +83.8% | 0.00% | +100.0% |
| Q4 2020 | $871,000 | -16.6% | 198,854 | +14.3% | 0.00% | 0.0% |
| Q3 2020 | $1,044,000 | +0.6% | 174,051 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $1,038,000 | -78.2% | 164,476 | -79.5% | 0.00% | -90.9% |
| Q1 2020 | $4,766,000 | +1.2% | 802,378 | -3.4% | 0.01% | +83.3% |
| Q4 2019 | $4,709,000 | – | 830,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 2,900,000 | $12,702,000 | 3.02% |
| P.A.W. CAPITAL CORP | 750,000 | $3,285,000 | 2.90% |
| Prosight Management, LP | 824,795 | $3,613,000 | 1.67% |
| Voss Capital, LLC | 715,000 | $3,132,000 | 1.58% |
| DRW Securities, LLC | 7,976,176 | $34,936,000 | 1.23% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $6,172,000 | 1.06% |
| Nantahala Capital Management | 7,272,673 | $31,854,000 | 0.99% |
| SANDERS MORRIS HARRIS LLC | 925,153 | $4,231,000 | 0.96% |
| PRECEPT MANAGEMENT LLC | 440,696 | $1,930,000 | 0.78% |
| Endurant Capital Management LP | 477,895 | $2,093,000 | 0.76% |